We have located links that may give you full text access.
National Trends of Cerebral Venous Sinus Stenting for the Treatment of Idiopathic Intracranial Hypertension.
Neurology 2023 March 30
BACKGROUND: Cerebral venous sinus stenting (VSS) has emerged as a new surgical procedure for the treatment of severe IIH, and its popularity has been anecdotally on the rise. This study explores recent temporal trends of VSS and other surgical IIH treatments in the United States.
METHODS: Adult IIH patients were identified from the 2016-20 National Inpatient Sample databases, and surgical procedures and hospital characteristics were recorded. Temporal trends of procedure numbers for VSS, cerebrospinal fluid (CSF) shunts, and optic nerve sheath fenestrations (ONSF) were assessed and compared.
RESULTS: 46,065 [95%CI: 44,710-47,420] IIH patients were identified, of whom 7,535 patients [95%CI: 6,982-8,088] received surgical IIH treatments. VSS procedures increased 80% (150 [95%CI: 55-245] to 270 [95%CI: 162-378] per year, p<0.001). Concurrently, the number of CSF shunts decreased by 19% (1365 [95%CI: 1,126-1,604] to 1105 [95%CI: 900-1,310] per year, p<0.001), and ONSF procedures decreased by 54% (65 [95%CI: 20-110] to 30 [95%CI: 6-54] per year, p<0.001).
CONCLUSIONS: Practice patterns for surgical IIH treatment in the United States are rapidly evolving, and VSS is becoming increasingly common. These findings highlight the urgency of randomized controlled trials to investigate the comparative effectiveness and safety of VSS, CSF shunts, ONSF, and standard medical treatments.
METHODS: Adult IIH patients were identified from the 2016-20 National Inpatient Sample databases, and surgical procedures and hospital characteristics were recorded. Temporal trends of procedure numbers for VSS, cerebrospinal fluid (CSF) shunts, and optic nerve sheath fenestrations (ONSF) were assessed and compared.
RESULTS: 46,065 [95%CI: 44,710-47,420] IIH patients were identified, of whom 7,535 patients [95%CI: 6,982-8,088] received surgical IIH treatments. VSS procedures increased 80% (150 [95%CI: 55-245] to 270 [95%CI: 162-378] per year, p<0.001). Concurrently, the number of CSF shunts decreased by 19% (1365 [95%CI: 1,126-1,604] to 1105 [95%CI: 900-1,310] per year, p<0.001), and ONSF procedures decreased by 54% (65 [95%CI: 20-110] to 30 [95%CI: 6-54] per year, p<0.001).
CONCLUSIONS: Practice patterns for surgical IIH treatment in the United States are rapidly evolving, and VSS is becoming increasingly common. These findings highlight the urgency of randomized controlled trials to investigate the comparative effectiveness and safety of VSS, CSF shunts, ONSF, and standard medical treatments.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app